M.v.i. and Death - a phase IV clinical study of FDA data

Summary:

Death is reported as a side effect among people who take M.v.i. (ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e), especially for people who are male, 60+ old, have been taking the drug for 1 - 2 years also take Carboplatin, and have Hepatitis c.

The study is created by eHealthMe based on reports of 2,495 people who have side effects when taking M.v.i. from the FDA, and is updated regularly.

What is M.v.i.?

M.v.i. has active ingredients of ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e. eHealthMe is studying from 2,498 M.v.i. users. Check the latest studies of M.v.i..

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Jul, 26, 2026

2,495 people reported to have side effects when taking M.v.i..
Among them, 17 people (0.68%) died.

Among these 17 people:

How long have people been on M.v.i. when they died? *

What is the gender of people who died when taking M.v.i.? *

female: 35.29 %
male: 64.71 %

What is the age of people who died when taking M.v.i.? *

What are other drugs people take besides M.v.i.? *

What are other side effects people have before they died? *

Gastrointestinal Perforation (hole in the digestive tract): 2 people, 11.76%
Fainting (loss of consciousness and postural tone): 2 people, 11.76%
Sepsis (a severe blood infection that can lead to organ failure and death): 2 people, 11.76%
Rashes (redness): 2 people, 11.76%
Constipation: 2 people, 11.76%
Dyspnea (difficult or laboured breathing): 2 people, 11.76%
Aortic Aneurysm Rupture (enlarged aortic artery rapture caused by a weakening of the artery wall): 1 person, 5.88%
Bone Marrow Depression (decreased ability or inability of the bone marrow to produce blood cells): 1 person, 5.88%
Breathing - Slowed Or Stopped: 1 person, 5.88%
Consciousness - Decreased: 1 person, 5.88%

What are the existing conditions these people have? *

Hepatitis C: 3 people, 17.65%
Breast Cancer Metastatic: 2 people, 11.76%
Pain: 2 people, 11.76%
Lung Cancer - Non-Small Cell (lung cancer): 2 people, 11.76%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 5.88%
Cardiac Disorder: 1 person, 5.88%
Dyspnea (difficult or laboured breathing): 1 person, 5.88%
Gastric Cancer (stomach cancer): 1 person, 5.88%
Glioblastoma Multiforme (most common and deadliest of malignant primary brain tumours in adults): 1 person, 5.88%
Iron Overload: 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Related studies:

Effectiveness of, long term effects of, and alternative drugs to M.v.i.:

M.v.i. (2,498 reports)

Expand to all the drugs that have ingredients of ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e:

Death and drugs with ingredients of ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e (5,887 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of M.v.i.:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Death:

Death (3,107 drugs)

Browse all the conditions that are associated with Death:

Death (3,686 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e (the active ingredients of M.v.i.) and M.v.i. (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.